Isolation of hepatitis A virus strain HM-175

ABSTRACT

Human hepatitis A virus (HAV), taken directly from human clinical specimens, can be isolated and serially passaged in primary African green monkey kidney (AGMK) cell cultures. This strain induced antibody to HAV in inoculated chimpanzees and is useful for vaccine.

This is a continuation of application Ser. No. 366,165, filed Apr. 7,1982, now U.S. Pat. No. 4,532,215.

BACKGROUND OF THE INVENTION

Hepatitis A virus (HAV) has only recently been propagated in cellcultures and is very difficult to isolate. There are no more than six oreight strains yet isolated, and most of them require passage throughanother species or in cell lines that are not suitable for vaccinedevelopment. Since HAV cannot be produced in large quantities fromtissure culture cells, the development of in vitro culture systemsdepended upon the development of the HAV-specific detection system byimmunofluorescence (IF).

At the present time, marmosets are the major source for production ofhepatitis A virus (HAV) and hepatitis A antigen (HA Ag). However, thedecreasing availability of these animals and the high cost of acquiringand maintaining them necessitates an alternative source of antigen forserologic testing. This invention describes the HM-175 strain of HAVsuitable for the production of tissue culture-grown HA Ag as an antigenfor radioimmunoassay of anti-HAV.

The isolation of HAV directly from clinical specimens into a cell linefor vaccine production (primary AGMK) suggests that additional in vitrocultivation of the virus will yield a strain suitable for vaccinedevelopment.

PRIOR ART STATEMENT

Provost et al, U.S. Pat. No. 4,164,566, teaches the development of invitro Hepatitis A virus (HAV) cell cultures. Provost et al, however,uses a different strain of HAV which requires at least 5 passages in asub-human primate in order to produce HAV. The purpose of this inventionis to show that HAV can be isolated and serially passaged in primaryAfrican green monkey kidney (AGMK) cell cultures taken directly fromhuman clinical specimens.

Daemer et al, Infection and Immunity, Vol. 32, No. 1, Apr. 1981, pp388-393.

UTILITY STATEMENT

The growth of hepatitis A virus, strain HM-175 in primary African greenmonkey kidney provides a reliable and continuous source for thepropagation of this virus and viral antigens. The antigen produceddirectly from this tissue culture provides material for vaccineproduction and for serologic testing.

DETAILED DESCRIPTION OF PROCESS

A new strain of HAV, HM-175, was isolated from clinical specimensderived from an outbreak of the virus in Australia. Stool suspensionswere prepared either as 2% or 20% extracts in phosphate-buffered saline(PBS), pH 7.4, clarified by low speed centrifugation, and stored at -70°C.

CELL CULTURES

Primary cell cultures of African Green Monkey kidneys (AGMK) were usedfor virus propagation. The maintenance medium was Eagle's minimalessential medium (MEM) with Earle's salts and 25 mM Hepes buffer. Themedium was supplemented with 2% inactivated fetal bovine serum (FBS), 50ug/ml of gentamicin, 2 u g/ml fungizone, and 2 mM glutamine. Thecultures were then maintained in the medium at 37° C. for many weeks.

VIRUS PROPAGATION (a) Primary isolation

Cultures of AGMK cells were washed twice with Hanks balanced saltsolution (HBSS) and inoculated with 0.1 ml of either a 10⁻¹ or 10⁻²dilution of stool material prepared as directed in the previousparagraph. The cells were allowed a 2-hour period of absorption, afterwhich they were again sustained in maintenance medium and incubated at37° C. The cultures were assayed by direct immunofluorescence forhepatitis A antigen (HA Ag) at weekly intervals.

(b) Serial passage

AGMK cells wee initially inoculated with 0.1 ml of a 1:20 dilution ofstool containing HM-175 virus. For serial passage, the cells wereharvested by treatment with trypsin-EDTA (ethylenediamintetraaceticacid), pelleted by low speed centrifugation and resuspended in 4 ml ofmaintenance medium.

(c) Immunofluorescence

Direct immunofluorescence was performed by staining withfluorescein-conjugated hyperimmune serum from a chimpanzee which hadbeen infected with the MS-1 strain of HAV.

(d) Blocking tests

To confirm the specificity of the IF reactions, blocking tests wereperformed under code with paired sera from humans naturally infectedwith type A hepatitis and paired sera from a chimpanzee experimentallyinfected with the MS-1 strain of HAV. Blocking experiments wereperformed by preincubating the coverslips for 15 minutes with a 1:5dilution of the serum to be tested. The slides were then stained with a1:200 dilution of conjugated chimpanzee serum.

RESULTS

Table 1 lists attempts to isolate HAV in AGMK from clinical specimensthat contained one of three different strains of HAV. Little or noantigen was detected in the cultures inoculated with MS-1 or SD-11. Inthe cell cultures inoculated with stool extract containing HM-175, HA Agwas observed in a small number of cells after seven days, both thenumber of cells and the intensity of staining increased with time. By 21days post inoculation, scattered single fluorescing cells and foci ofintensely fluorescing cells could be seen.

Cells inoculated with the 3-week or 8-week cell harvest of the firstAGMK passage (HM-175 M-6, AGMK-1) were positive by IF for viral antigenby 2 weeks after inoculation (Table 2). The cells inoculated with the3-week harvest remained positive by IF for at least 6 weeks, at whichtime the cells were harvested with trypsin-EDTA and used for a thirdcell passage. Whole cells were used because the viral antigen appearedto be cell associated, suggesting that cell-to-cell contact mightfacilitate infection of the cells. Weak but positive fluorescence wasdetected at 2 weeks after which no fluorescence was observed(fluorescence was subsequently detected at 11 weeks in the AGMK-3culture maintained for that period of time). The cells were blind-passed(AGMK-4) at week 6, showing positive by 3-weeks postinoculation. By pass5, fluorescence was detected at 1 week; by 3 weeks the intensity ofstaining and number of cells fluorescing had increased to greater than75%. In the 6th passage, the cells were positive after 1 week and after3 weeks, almost all cells were stained. Pass 7 cells were positive at 1week and, by 5 weeks, most cells were positive.

                  TABLE 1    ______________________________________    HAV IN AGMK CELL CULTURE: Primary Isolation                  IF by Week.sup.a    Strain     Inoculum 1          2    3    ______________________________________    MS-1       Stool    -          -    -    MS-1       Serum    -          -    -    SD-11      Stool    ±       .sup. -.sup.b                                        ±    SD-11      Serum    -          1    2    HM-175     Stool    1          1    3    ______________________________________     .sup.a Fluoresceinlabeled antiHAV was applied to acetonefixed cell cultur     coverslips. The amount of HA Ag was determined on a scale of 1 to 4. 4     indicates that the cell sheet contained almost 100% intensely staining     cells.     .sup.b 10.sup.-1 dilution of inoculum; nonspecific cell deterioration     evident with 10.sup.-2 dilution.

                  TABLE 2    ______________________________________     HAV IN AGMK CELL CULTURE -    Cell Culture Passage (HM 175)    Mar-    moset  AGMK     IF by Week    Passage           Passage  1     2    3    4    6    8      11    ______________________________________    0      1            1    -*  +    1    1    2      4           2                                     4*           3            -   ± 3     4*           4            2   2    4     4*           5            1   2    3     4*           6            1   1     3*           7            1   2    2     2*    6      1            2   3     4*            (RIA+)*           2     (3)**  -   4    4     1*                 (8)    1   1    4    4     4*           3     (3)    -   1    -    -    -*   -      4                 (8)    1   1    1    1    ±*                                                -      4           4     (3)    -   -    1    2    2*                 (8)    -   -    1    2    2*           5     (3)    2   3    3     4*                 (8)    2   2    3     4*           6     (3)    1   2     3*                 (8)    1   2     3*           7     (3)    2   2    2    2                 (8)    ±                            1    3    3    ______________________________________     *Used for passage     **The second passage was made from a 3week harvest and an 8week harvest.     These were then maintained and passaged separately.

In the case of the cells inoculated with the AGMK-1, 8-week harvest,granular cytoplasmic fluorescence was observed by one week afterinoculation, although only approximately 1% of the cells were positivelystained at that time. By 4 weeks, the number of positive cells hadincreased substantially to 80-90%. Cells were harvested at 6 weeks bytreatment with trypsin-EDTA and used for a third passage in cellculture. As with the 3-week harvest above, whole cells were used.Radioimmunoassay (RIA) of this cell harvest yielded a P/N of 8.4. Weakbut positive fluorescence was observed in the pass 3 cultures up to timeof harvest at 6 weeks after inoculation. Pass 4 cultures were positiveat 3 weeks. By pass 5, fluorescence was positive at 1 week and mostcells were stained at 2 weeks. Pass 6 cells were positive at 1 week. By3 weeks, about 60% of the cells were stained. In 7th passage, greaterthan 90% of the cells were positive by 5 weeks.

Inoculation of cells with the stool extract containing HM-175 wasrepeated, and the cells were maintained for a longer period of time(Table 2). Intense granular fluorescence in occasional cells wasobserved after 1 week. The fluorescence then disappeared during weeks 2and 3 but could be observed again after 4 weeks, when very few cellswere positively stained but focal fluorescence was observed. At 8 weeks,intensely staining focal areas of rounded cells were observed. Positivefluorescence continued through the final observation at 12 weeks.

Two weeks after inoculation, whole cells harvested from the first AGMKcell passage of HM-175 stool (flasks) were used for pass 2 inoculationsof cells in T-75 flasks. At eight weeks, cells scraped from these pass 2flask cultures were strongly positive for antigen and almost all cellswere stained. The RIA (P/N) value of the cell extract was 14.3. The RIAof the supernatant was negative. Pass 2 cells were used for pass 3.Almost 100% of the pass 3 cells exhibited intense staining by four weekspostinoculation, and the RIA of the cell extract was 23.7. RIA of thesupernatant was again negative. Two weeks after inoculation of thefourth passage, intense fluorescence was observed in approximately 10%of the cells. By 3 weeks, intense staining was observed in approximately60% of the cells. At 5 weeks almost 100% of the cells were stained, andthe RIA P/N was 22.4 on the extract of the cell pellet, but negative onthe supernatant. Blocking experiments with hyperimmune chimpanzee serumat this passage level confirmed the specificity of the fluorescence:convalescent but not preinfection serum completely blocked thefluorescence. Pass 5 cultures were positive after 1 week, and by 3weeks, 80-90% of the cells were intensely stained. Blocking experimentsat this passage level were performed with paired humal pre-exposure andconvalescent sera and pre-exposure and hyperimmune chimpanzee sera. Onlythe sera containing anti-HAV blocked the fluorescence. Pass 6 and 7cells were also positive by 1 week and the number of positive cellsincreased with time.

The specificity of the tissue culture-derived HA Ag was further provenby RIA blocking experiments--when used as the source of antigen for asolid-phase RIA blocking test, the HA AG reactivity was blocked byconvalescent sera from a chimpanzee and a marmoset experimentallyinfected with the HM-175 strain of HAV and by convalescent sera fromthree humans who were naturally infected with the SD-11 strain of HAV.None of the pre-infection sera blocked HA Ag reactivity, nor did pre-and convalescent-sera from one human and two chimpanzee cases ofhepatitis B virus infection.

This invention shows that HAV can be isolated and serially propagated inAGMK cell culture taken directly from human specimens. The virusisolated from stool experienced an eclipse phase lasting approximately 4weeks, after which the amount of HA Ag increased. The serial passage ofHM-175 substantially decreases the interval to maximum intracellular HAAg expression.

EXAMPLES

Primary isolation of HAV in AGMK cell culture was conducted according tothe specifications of this application using three strains of HAV: MS-1,SD-11, and HM-175. The cells were stained by direct immunofluorescence(IF) to establish the identify of the virus. Fluorescein-labeledanti-HAV was applied to acetone-fixed cell culture coverslips. Theamount of HA Ag was determined on a scale of 1 to 4, 4 indicating thatthe cell sheet contained almost 100% intensely staining cells. Theresults are shown below:

    ______________________________________                  IF by Week    Strain     Inoculum 1          1    3    ______________________________________    MS-1       Stool    -          -    -    MS-1       Serum    -          -    -    SD-11      Stool    ±       -    ±    SD-11      Serum    -          1    2    HM-175     Stool    1          1    3    ______________________________________

For additional experiments, see Table 2.

We claim:
 1. A method for the direct isolation of HAV strain HM-175taken from stool samples of humans with acute hepatitis A virus,propagating the virus in a suitable substrate, and serially passagingsaid virus to form an agent for a vaccine without interposition of amammalian model.
 2. A method for the in vitro propagation of hepatitis Avirus by cultivating HAV strain HM-175 in primary African Green Monkeykidney (AGMK) cell cultures, and serially passaging said virus at least5 times in AGMK without the interposition of a mammalian model.
 3. Inthe method for direct isolation of HAV taken from stool samples ofhumans with acute hepatitis A, and further isolating and propagating thevirus in a suitable substrate, the step which comprises directlypassaging said virus in tissue culture cells to form a serological testor radioimmunoassay of anti-HAV without interposition of a mammalianmodel.